1-5 of 5
Juan Carlos Montero
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer

Free
Ana Alcaraz-Sanabria, Cristina Nieto-Jiménez, Verónica Corrales-Sánchez, Leticia Serrano-Oviedo, Fernando Andrés-Pretel, Juan Carlos Montero, Miguel Burgos, Juan Llopis, Eva María Galán-Moya, Atanasio Pandiella, Alberto Ocaña
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (11): 2552–2562.
https://doi.org/10.1158/1535-7163.MCT-17-0223
Published: 01 November 2017
View articletitled, Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer
Open the PDF for Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment

Free
Javier Pérez-Peña, Gemma Serrano-Heras, Juan Carlos Montero, Verónica Corrales-Sánchez, Atanasio Pandiella, Alberto Ocaña
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (8): 1823–1833.
https://doi.org/10.1158/1535-7163.MCT-16-0004
Published: 03 August 2016
View articletitled, In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment
Open the PDF for In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment in another window
Includes: Supplementary data
Journal Articles

Predominance of mTORC1 over mTORC2 in the Regulation of Proliferation of Ovarian Cancer Cells: Therapeutic Implications

Free
Juan Carlos Montero, Xi Chen, Alberto Ocaña, Atanasio Pandiella
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (6): 1342–1352.
https://doi.org/10.1158/1535-7163.MCT-11-0723
Published: 10 June 2012
View articletitled, Predominance of mTORC1 over mTORC2 in the Regulation of Proliferation of Ovarian Cancer Cells: Therapeutic Implications
Open the PDF for Predominance of mTORC1 over mTORC2 in the Regulation of Proliferation of Ovarian Cancer Cells: Therapeutic Implications in another window
Includes: Supplementary data
Journal Articles

Abstract B39: Action of EC8042 in triple-negative breast cancer.

Free
Atanasio Pandiella, Juan Carlos Montero, Lolin Cuenca-Lopez, Florencia Re-Louhau, Francisco Moris, Alberto Ocana
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B39.
https://doi.org/10.1158/1535-7163.TARG-11-B39
Published: 12 November 2011
View articletitled, Abstract B39: Action of EC8042 in triple-negative breast cancer.
Journal Articles

Mitogen-activated Protein Kinase Routes as Targets in the Action of Diaza-anthracene Compounds with a Potent Growth-inhibitory Effect on Cancer Cells

Free
Carlos Pipaón, Pilar Gutierrez, Juan Carlos Montero, Mariluz Lorenzo, Ana Eguiraun, Jesús A. De la Fuente, Atanasio Pandiella, Javier León, José M. Ortiz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (10): 811–819.
Published: 01 August 2002
View articletitled, Mitogen-activated Protein Kinase Routes as Targets in the Action of Diaza-anthracene Compounds with a Potent Growth-inhibitory Effect on Cancer Cells
Open the PDF for Mitogen-activated Protein Kinase Routes as Targets in the Action of Diaza-anthracene Compounds with a Potent Growth-inhibitory Effect on Cancer Cells in another window